Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Centella Asiatica extract - Oneness Biotech

Next Previous
Drug Profile

Centella Asiatica extract - Oneness Biotech

Alternative Names: COMPLEHEAL™; DCB WH1; Fespixon; Fespixon® cream; ON-101; ONENESS™; PA-F4; Plectranthus amboinicus extract - Oneness Biotech; S1; WH 1

Latest Information Update: 05 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Development Center for Biotechnology
  • Developer HaiHe Biopharma; Oneness Biotech
  • Class Flavanones; Foot disorder therapies; Herbal medicines; Terpenes
  • Mechanism of Action Macrophage modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Diabetic foot ulcer

Highest Development Phases

  • Marketed Diabetic foot ulcer

Most Recent Events

  • 28 Jun 2024 Oneness Biotech terminates the phase III trial for Diabetic foot ulcer in USA (Topical) due to the product development strategy adjustment (NCT04962139)
  • 02 Oct 2023 Updated efficacy data from the phase III MRCT trial in Diabetic foot ulcer presented at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD-2021)
  • 31 Jan 2023 Registered for Diabetic foot ulcer in Singapore (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top